Feb 28 (Reuters) - Somnomed Ltd (SOM) :
- HY NET LOSS ATTRIBUTABLE A$6.3 MILLION
- HY REVENUES FROM ORDINARY ACTIVITIES UP 12.9% TO A$45.1 MILLION
- REMAINS OPTIMISTIC ABOUT TRADING ACTIVITY LEVELS AND THE OUTLOOK FOR THE SECOND HALF OF FY24
- SEES FY24 REVENUE GROWTH OF AT LEAST 12%
- SEES FY24 EBITDA OF AT LEAST A$3 MILLION
- SEES FY24 CAPITAL EXPENDITURE OF A$5 MILLION
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $163.6M | |||
| Open | High | Low | Value | Volume |
| 75.0¢ | 75.0¢ | 73.5¢ | $37.09K | 50.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14661 | 73.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.0¢ | 101723 | 2 |
View Market Depth
| Last trade - 15.56pm 10/09/2025 (20 minute delay) ? |
| SOM (ASX) Chart |